Valuation: Albert David Limited

Market Cap 3.91B 40.41M 35.54M 33.02M 30.37M 56.95M 57.97M 395M 154M 1.91B 152M 148M 6.62B P/E 2025
26.9x
P/E 2026 -224x
Enterprise Value 1.63B 16.87M 14.84M 13.78M 12.68M 23.77M 24.2M 165M 64.29M 797M 63.33M 61.96M 2.76B EV / Sales 2025
0.67x
EV / Sales 2026 0.32x
Free-Float
35.96%
Yield 2025
0.62%
Yield 2026 0.85%
1 day-0.57%
1 week-1.96%
Current month-2.25%
1 month-3.86%
3 months-7.97%
6 months-0.42%
Current year-7.20%
1 week 678
Extreme 678
705
1 month 678
Extreme 678
723
Current year 579.9
Extreme 579.9
819.6
1 year 579.9
Extreme 579.9
922.15
3 years 579.9
Extreme 579.9
1,753.95
5 years 486.85
Extreme 486.85
1,753.95
10 years 263
Extreme 263
1,753.95
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO - 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 14/11/2024
Chairman 73 30/12/2009
Director/Board Member 68 31/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%-1.96% - - 40.7M
+0.57%+0.13%+16.45%+78.10% 48.31B
-0.50%-0.41%+67.13%+107.90% 35.33B
-1.56%-3.13%-4.88%+32.80% 11.85B
-1.11%-3.73%+16.41%+81.64% 11.64B
-0.84%-0.19%+36.48%+136.73% 8.99B
-0.27%+0.42%+51.66%-6.22% 6.93B
-0.77%-3.48%+13.66%+30.68% 6.72B
+0.24%-4.02%+2.19%+192.78% 6.43B
+1.60%-9.55%-30.77%+8.47% 5.66B
Average -0.30%-1.73%+18.70%+73.65% 15.76B
Weighted average by Cap. -0.17%-0.93%+27.61%+81.80%

Financials

2025 2026
Net sales 3.46B 35.7M 31.4M 29.17M 26.83M 50.32M 51.22M 349M 136M 1.69B 134M 131M 5.85B 3.34B 34.45M 30.3M 28.15M 25.89M 48.55M 49.42M 337M 131M 1.63B 129M 127M 5.65B
Net income 172M 1.78M 1.56M 1.45M 1.33M 2.5M 2.55M 17.35M 6.77M 83.9M 6.67M 6.52M 291M -14.95M -154K -136K -126K -116K -218K -221K -1.51M -588K -7.29M -579K -567K -25.29M
Net Debt -2.31B -23.89M -21.01M -19.52M -17.95M -33.66M -34.27M -233M -91.04M -1.13B -89.68M -87.74M -3.91B -2.28B -23.54M -20.71M -19.24M -17.69M -33.18M -33.77M -230M -89.72M -1.11B -88.39M -86.48M -3.86B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,476
Date Price Change Volume
23/07/26 INR 683.55 -0.57% 3,881
22/07/26 INR 687.50 -1.26% 1,652
21/07/26 INR 696.30 -0.24% 2,337
20/07/26 INR 698.00 -0.33% 4,064
17/07/26 INR 700.30 +0.88% 1,328